566 related articles for article (PubMed ID: 25410967)
1. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
2. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.
Shojaee S; Nokhodchi A; Maniruzzaman M
Drug Deliv Transl Res; 2017 Feb; 7(1):111-124. PubMed ID: 27873080
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Drug Release from PEO Tablet Matrices in the Presence of Vitamin E as Antioxidant.
Shojaee S; Nokhodchi A; Cumming I; Alhalaweh A; Kaialy W
Curr Drug Deliv; 2015; 12(5):591-9. PubMed ID: 25808280
[TBL] [Abstract][Full Text] [Related]
5. The role of fillers and sodium metabisulfite on drug release from aged polyox tablets.
Shojaee S; Nokhodchi A; Cumming I
Drug Dev Ind Pharm; 2014 Nov; 40(11):1451-8. PubMed ID: 23962147
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
Akbari J; Nokhodchi A; Farid D; Adrangui M; Siahi-Shadbad MR; Saeedi M
Farmaco; 2004 Feb; 59(2):155-61. PubMed ID: 14871508
[TBL] [Abstract][Full Text] [Related]
7. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
[TBL] [Abstract][Full Text] [Related]
8. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
9. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.
Kim CJ
Drug Dev Ind Pharm; 1998 Jul; 24(7):645-51. PubMed ID: 9876509
[TBL] [Abstract][Full Text] [Related]
10. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
Efentakis M; Iliopoyloy A; Siamidi A
Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
[TBL] [Abstract][Full Text] [Related]
11. The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices.
Palmer D; Levina M; Nokhodchi A; Douroumis D; Farrell T; Rajabi-Siahboomi A
AAPS PharmSciTech; 2011 Sep; 12(3):862-71. PubMed ID: 21710334
[TBL] [Abstract][Full Text] [Related]
12. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
Nie SF; Tang H; Guo H; Pan WS
Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
Wen H; Li X; Li Y; Wang H; Wang Y; Wang T; Pan W; Yang X
Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
[TBL] [Abstract][Full Text] [Related]
15. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
[TBL] [Abstract][Full Text] [Related]
16. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
17. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
18. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
Mamani PL; Ruiz-Caro R; Veiga MD
Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
[TBL] [Abstract][Full Text] [Related]
19. Effects of Drug-Polymer Interactions on Tablet Properties During the Development of Abuse-Deterrent Dosage Forms.
Meruva S; Donovan MD
AAPS PharmSciTech; 2019 Jan; 20(3):93. PubMed ID: 30690657
[TBL] [Abstract][Full Text] [Related]
20. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
Shojaee S; Emami P; Mahmood A; Rowaiye Y; Dukulay A; Kaialy W; Cumming I; Nokhodchi A
AAPS PharmSciTech; 2015 Dec; 16(6):1281-9. PubMed ID: 25771738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
